Search Results
Kate M Warde
Kate M Warde
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Kate M Warde in
Google Scholar
PubMed
Search for other papers by Kate M Warde in
Google Scholar
PubMed
Erik Schoenmakers
Erik Schoenmakers
Metabolic Research Laboratories, Wellcome Trust–MRC Institute of Metabolic Science-University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Erik Schoenmakers in
Google Scholar
PubMed
Search for other papers by Erik Schoenmakers in
Google Scholar
PubMed
Eduardo Ribes Martinez
Eduardo Ribes Martinez
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Eduardo Ribes Martinez in
Google Scholar
PubMed
Search for other papers by Eduardo Ribes Martinez in
Google Scholar
PubMed
Yi Jan Lim
Yi Jan Lim
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Yi Jan Lim in
Google Scholar
PubMed
Search for other papers by Yi Jan Lim in
Google Scholar
PubMed
Maeve Leonard
Maeve Leonard
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Maeve Leonard in
Google Scholar
PubMed
Search for other papers by Maeve Leonard in
Google Scholar
PubMed
Sarah J Lawless
Sarah J Lawless
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Sarah J Lawless in
Google Scholar
PubMed
Search for other papers by Sarah J Lawless in
Google Scholar
PubMed
Paula O’Shea
Paula O’Shea
Department of Clinical Biochemistry, Galway University Hospitals, Saolta Hospitals Group, Galway, Ireland
Search for other papers by Paula O’Shea in
Google Scholar
PubMed
Search for other papers by Paula O’Shea in
Google Scholar
PubMed
Krishna V Chatterjee
Krishna V Chatterjee
Metabolic Research Laboratories, Wellcome Trust–MRC Institute of Metabolic Science-University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Krishna V Chatterjee in
Google Scholar
PubMed
Search for other papers by Krishna V Chatterjee in
Google Scholar
PubMed
Mark Gurnell
Mark Gurnell
Metabolic Research Laboratories, Wellcome Trust–MRC Institute of Metabolic Science-University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Constanze Hantel
Constanze Hantel
Department of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Michael Conall Dennedy
Michael Conall Dennedy
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland
Search for other papers by Michael Conall Dennedy in
Google Scholar
PubMed
Search for other papers by Michael Conall Dennedy in
Google Scholar
PubMed
of the ER stress markers CHOP and XBP1 S/U in mitotane-treated H295R across all concentrations, which increased in combination with either LXRα inhibitor ( Fig. 2C ). Figure 2 (A) Graphical representation of percentage AnnexinV positive
Adam Stenman
Adam Stenman
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Adam Stenman in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Adam Stenman in
Google Scholar
PubMed
Samuel Backman
Samuel Backman
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Search for other papers by Samuel Backman in
Google Scholar
PubMed
Search for other papers by Samuel Backman in
Google Scholar
PubMed
Klara Johansson
Klara Johansson
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Klara Johansson in
Google Scholar
PubMed
Search for other papers by Klara Johansson in
Google Scholar
PubMed
Johan O Paulsson
Johan O Paulsson
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Johan O Paulsson in
Google Scholar
PubMed
Search for other papers by Johan O Paulsson in
Google Scholar
PubMed
Peter Stålberg
Peter Stålberg
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Jan Zedenius
Jan Zedenius
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
C Christofer Juhlin
C Christofer Juhlin
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
among established genes None SQSTM1-NTRK3 None BRAF V600E NCOA4-RET Constitutional event* CHEK2 p.410fs None None None None Mutational aggregation in primary tumor # XBP1(S) activates chaperone genes Translocation of
Catherine Zabkiewicz
Catherine Zabkiewicz
Cardiff China Medical Research Collaborative Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Catherine Zabkiewicz in
Google Scholar
PubMed
Search for other papers by Catherine Zabkiewicz in
Google Scholar
PubMed
Jeyna Resaul
Jeyna Resaul
Cardiff China Medical Research Collaborative Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Jeyna Resaul in
Google Scholar
PubMed
Search for other papers by Jeyna Resaul in
Google Scholar
PubMed
Rachel Hargest
Rachel Hargest
Cardiff China Medical Research Collaborative Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Rachel Hargest in
Google Scholar
PubMed
Search for other papers by Rachel Hargest in
Google Scholar
PubMed
Wen Guo Jiang
Wen Guo Jiang
Cardiff China Medical Research Collaborative Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Wen Guo Jiang in
Google Scholar
PubMed
Search for other papers by Wen Guo Jiang in
Google Scholar
PubMed
Lin Ye
Lin Ye
Cardiff China Medical Research Collaborative Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Lin Ye in
Google Scholar
PubMed
Search for other papers by Lin Ye in
Google Scholar
PubMed
, Smad2, Map3k1, Tob1, Ywhag/14-3-3γ, Ywhab/14-3-3β, Smad5, Zfp36, Xbp1, Mapk12 and Snail ( Perdigao-Henriques et al . 2016 ). BMP-2 appears to promote motility and invasiveness of MCF-7 and MDA-MB-231 cells, both in vitro and in vivo ( Clement et
